Capmatinib is a special kind of medicine that targets a specific problem in NSCLC with a certain type of mutation. It zeroes in on the MET kinase to slow down tumor growth. You can get this med in two doses: 150 mg and 200 mg tablets with a film coating.
You should take 400 mg of this stuff, twice a day—either with food or not. These tablets come in bottles, with each bottle holding 60 of them. The treatment works by blocking something called the MET tyrosine kinase, which is a big deal in certain types of NSCLC, especially when there’s a skip in the MET exon 14.
The tablets are made to be taken at just the right amount and at regular times to keep the disease from getting worse.
Reviews
There are no reviews yet.